Chen J, Wang R, Zhang B, Lin X, Wei J, Jia Y, et al
. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis. Am J Obstet Gynecol. 2016;215:460.e1-460.e13 pubmed publisher
..In women with early-stage cervical adenocarcinoma without these risk factors, ovarian conservation can be considered. ..
Zhou B, Xu H, Xia M, Sun C, Li N, Guo E, et al
. Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer. Front Med. 2017;11:214-222 pubmed publisher
..Thus, our study demonstrates that miR-9 may promote ovarian cancer metastasis via targeting E-cadherin and a novel potential therapeutic approach to control metastasis of ovarian cancer. ..
Yang B, Yu Y, Chen J, Zhang Y, Yin Y, Yu N, et al
. Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely and successfully become pregnant-a Chinese retrospective cohort study among 148 cases. Front Med. 2017;: pubmed publisher
..FSS followed by ACT appeared to have little or no effect on fertility. Meanwhile, postoperative pregnancy did not increase the PFS or OS. Use of gonadotropin-releasing hormone agonist was not beneficial for fertility...
Xia X, Ma Q, Li X, Ji T, Chen P, Xu H, et al
. Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer. BMC Cancer. 2011;11:399 pubmed publisher
..Cytoplasmic p21 is a novel biomarker of cisplatin resistance and it may represent a potential therapeutic target for ovarian tumors that are refractory to conventional treatment. ..